Optimal timing for prediction of pathologic complete response to neoadjuvant chemoradiotherapy with diffusion-weighted MRI in patients with esophageal cancer

• DOI: 10.1007/s00330-019-06513-0
• Publication Date: 2019-12-10T10:03:01Z
• Authors: Alicia S. Borggreve; Sophie E. Heethuis; Mick R. Boekhoff; Lucas Goense; Peter S. N. van R...; Lodewijk A. A. Br...; Astrid L. H. M. W...; Richard van Hille...; Jan J. W. Lagendijk; Stella Mook; Jelle P. Ruurda; Gert J. Meijer
• Keywords: Neuroradiology; Chemoradiotherapy; Histology; Neoadjuvant Therapy

This study was conducted in order to determine the optimal timing of diffusion-weighted magnetic resonance imaging (DW-MRI) for prediction pathologic complete response (pCR) neoadjuvant chemoradiotherapy (nCRT) esophageal cancer.